相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury-Mediated Chronic Kidney Disease Role of Oxidative Stress
Lionel Lattenist et al.
HYPERTENSION (2017)
Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality
Juan Jesus Carrero et al.
KIDNEY INTERNATIONAL (2017)
Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis
Adam P. Harvey et al.
LIFE SCIENCES (2017)
The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
Jochen Dutzmann et al.
PLOS ONE (2017)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Genetic predisposition to albuminuria is associated with increased arterial stiffness: role of elastin
M. Gil-Ortega et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Nonsteroidal antagonists of the mineralocorticoid receptor
Peter Kolkhof et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1
Larbi Amazit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Mineralocorticoid Receptor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases
Johann Bauersachs et al.
HYPERTENSION (2015)
Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: An emerging paradigm in diabetic nephropathy A systematic review
Thomas A. Mavrakanas et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)
Prognostic Value of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension
Jose Maria Pascual et al.
HYPERTENSION (2014)
Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
Peter Kolkhof et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
Development of albuminuria and enhancement of oxidative stress during chronic renin-angiotensin system suppression
Gema Ruiz-Hurtado et al.
JOURNAL OF HYPERTENSION (2014)
Aldosterone antagonists for preventing the progression of chronic kidney disease
Davide Bolignano et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Mineralocorticoid Receptor Blockade Reduced Oxidative Stress in Renal Transplant Recipients: A Double-Blind, Randomized Pilot Study
Marcos Ojeda-Cervantes et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Mineralocorticoid receptor antagonists for therapy of coronary artery disease and related complications
Carolin Zwadlo et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
Bertram Pitt et al.
EUROPEAN HEART JOURNAL (2013)
Dissecting the genetic predisposition to albuminuria and endothelial dysfunction in a genetic rat model
Christoph Steireif et al.
JOURNAL OF HYPERTENSION (2013)
Vascular Actions of Aldosterone
Marie Briet et al.
JOURNAL OF VASCULAR RESEARCH (2013)
Evolving importance of kidney disease: from subspecialty to global health burden
Kai-Uwe Eckardt et al.
LANCET (2013)
Increased cardiovascular risk in rats with primary renal dysfunction; mediating role for vascular endothelial function
M. K. Szymanski et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Discovery of BAY 94-8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases
Lars Baerfacker et al.
CHEMMEDCHEM (2012)
Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease
Minoru Satoh
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Mapping genetic determinants of kidney damage in rat models
Angela Schulz et al.
HYPERTENSION RESEARCH (2012)
Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans
Thomas Thum et al.
EUROPEAN HEART JOURNAL (2011)
Elimination of Severe Albuminuria in Aging Hypertensive Rats by Exchange of 2 Chromosomes in Double-Consomic Rats
Nicole van Es et al.
HYPERTENSION (2011)
Albuminuria: all you need to predict outcomes in chronic kidney disease?
Ron T. Gansevoort et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
Kunihiro Matsushita et al.
LANCET (2010)
Proteinuria-Associated Endothelial Dysfunction Is Strain Dependent
Nadir Ulu et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Predictors of Hyperkalemia Risk following Hypertension Control with Aldosterone Blockade
Nitin Khosla et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Quantification of protein modification by oxidants
Clare L. Hawkins et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Genome-wide linkage scans for renal function and albuminuria in Type 2 diabetes mellitus: the Diabetes Heart Study
B. I. Freedman et al.
DIABETIC MEDICINE (2008)
Albuminuria, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: the Hoorn Study
Marc M. H. Hermansa et al.
JOURNAL OF HYPERTENSION (2008)
Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Fromter rats
D. H. T. IJpelaar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: The possible role of local renin-angiotensin system
Yuki Hirono et al.
ENDOCRINOLOGY (2007)
Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms
Coen D. A. Stehouwer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Eplerenone reduces oxidative stress and enhances eNOS in SHR:: Vascular functional and structural consequences
D Sanz-Rosa et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Vascular protection - Superoxide dismutase isoforms in the vessel wall
FM Faraci et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Cerebral vascular effects of reactive oxygen species: Recent evidence for a role of NADPH-oxidase
TM Paravicini et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2003)
Endothelial dilatory function predicts individual susceptibility to renal damage in the 5/6 nephrectomized rat
S Gschwend et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Spironolactone improves angiotensin-induced vascular changes and oxidative stress
A Virdis et al.
HYPERTENSION (2002)
Impaired coronary endothelial function in a rat model of spontaneous albuminuria
S Gschwend et al.
KIDNEY INTERNATIONAL (2002)
Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency
ND Vaziri et al.
HYPERTENSION (2002)
Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension
T Quaschning et al.
HYPERTENSION (2001)
Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure
DG Fogarty et al.
KIDNEY INTERNATIONAL (2000)
分享论文
